drugset / Trial / NCT03394677

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

NCT03394677 ↗

Phase 2 Completed 110 enrolled Dermavant Sciences GmbH
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multi-center, randomized, vehicle controlled, double-blind Phase 2 study in pediatric patients age 2-17 years old with mild to moderate atopic dermatitis.

Timeline

Start
2018-01-25
Primary completion
2018-07-02
Completion
2018-07-02

Drugs

EvaluationDrugModalityDoseRoute
Subject LOTAMILAST Small molecule 0.5 % Topical

Indications